Sign up to save your podcasts
Or
Share Optimizing androgen deprivation therapy (ADT) in advanced prostate cancer
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Optimizing androgen deprivation therapy (ADT) in advanced prostate cancer
touchEXPERT OPINIONS for touchONCOLOGY
An oncologist, a nurse and a urologist share their insights on the risks and benefits of androgen deprivation therapy, the barriers to equitable care and how to improve treatment adherence for patients with prostate cancer.
The experts
- Dr Tanya Dorff, City of Hope Comprehensive Cancer Center, Duarte, CA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Pfizer Inc. and is jointly provided by USF Health and touchIME.
For further information visit: touchoncology.com
View all episodes
By touchpodcasttouchEXPERT OPINIONS for touchONCOLOGY
An oncologist, a nurse and a urologist share their insights on the risks and benefits of androgen deprivation therapy, the barriers to equitable care and how to improve treatment adherence for patients with prostate cancer.
The experts
- Dr Tanya Dorff, City of Hope Comprehensive Cancer Center, Duarte, CA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Pfizer Inc. and is jointly provided by USF Health and touchIME.
For further information visit: touchoncology.com